• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nemo 样激酶降低突变型亨廷顿蛋白水平并减轻亨廷顿病。

Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington's disease.

机构信息

Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Hum Mol Genet. 2020 May 28;29(8):1340-1352. doi: 10.1093/hmg/ddaa061.

DOI:10.1093/hmg/ddaa061
PMID:32242231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7254850/
Abstract

Nemo-like kinase (NLK), an evolutionarily conserved serine/threonine kinase, is highly expressed in the brain, but its function in the adult brain remains not well understood. In this study, we identify NLK as an interactor of huntingtin protein (HTT). We report that NLK levels are significantly decreased in HD human brain and HD models. Importantly, overexpression of NLK in the striatum attenuates brain atrophy, preserves striatal DARPP32 levels and reduces mutant HTT (mHTT) aggregation in HD mice. In contrast, genetic reduction of NLK exacerbates brain atrophy and loss of DARPP32 in HD mice. Moreover, we demonstrate that NLK lowers mHTT levels in a kinase activity-dependent manner, while having no significant effect on normal HTT protein levels in mouse striatal cells, human cells and HD mouse models. The NLK-mediated lowering of mHTT is associated with enhanced phosphorylation of mHTT. Phosphorylation defective mutation of serine at amino acid 120 (S120) abolishes the mHTT-lowering effect of NLK, suggesting that S120 phosphorylation is an important step in the NLK-mediated lowering of mHTT. A further mechanistic study suggests that NLK promotes mHTT ubiquitination and degradation via the proteasome pathway. Taken together, our results indicate a protective role of NLK in HD and reveal a new molecular target to reduce mHTT levels.

摘要

Nemo 样激酶(NLK)是一种进化上保守的丝氨酸/苏氨酸激酶,在大脑中高度表达,但在成年大脑中的功能尚不清楚。在这项研究中,我们鉴定 NLK 是亨廷顿蛋白(HTT)的相互作用蛋白。我们报告 NLK 水平在 HD 人脑和 HD 模型中显著降低。重要的是,NLK 在纹状体中的过表达可减轻脑萎缩,保持纹状体 DARPP32 水平并减少 HD 小鼠中突变 HTT(mHTT)聚集。相比之下,NLK 的遗传减少会加重 HD 小鼠中的脑萎缩和 DARPP32 丧失。此外,我们证明 NLK 以激酶活性依赖性方式降低 mHTT 水平,而对小鼠纹状体细胞、人细胞和 HD 小鼠模型中的正常 HTT 蛋白水平没有明显影响。NLK 介导的 mHTT 降低与 mHTT 的磷酸化增强有关。在氨基酸 120 处丝氨酸的磷酸化缺陷突变(S120)消除了 NLK 对 mHTT 降低的作用,表明 S120 磷酸化是 NLK 介导的 mHTT 降低的重要步骤。进一步的机制研究表明,NLK 通过蛋白酶体途径促进 mHTT 的泛素化和降解。总之,我们的结果表明 NLK 在 HD 中具有保护作用,并揭示了降低 mHTT 水平的新分子靶标。

相似文献

1
Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington's disease.Nemo 样激酶降低突变型亨廷顿蛋白水平并减轻亨廷顿病。
Hum Mol Genet. 2020 May 28;29(8):1340-1352. doi: 10.1093/hmg/ddaa061.
2
Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.外源性NUB1表达对HDQ175/Q7小鼠纹状体的影响。
J Huntingtons Dis. 2016 Jun 13;5(2):163-74. doi: 10.3233/JHD-160195.
3
Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.在亨廷顿舞蹈症的基因模型中,普拉克索通过多巴胺D3受体减少可溶性突变型亨廷顿蛋白并保护纹状体神经元。
Exp Neurol. 2018 Jan;299(Pt A):137-147. doi: 10.1016/j.expneurol.2017.10.019. Epub 2017 Oct 19.
4
TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.TRiC亚基增强脑源性神经营养因子的轴突运输并挽救亨廷顿舞蹈病中的纹状体萎缩。
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5655-64. doi: 10.1073/pnas.1603020113. Epub 2016 Sep 6.
5
Serine 421 regulates mutant huntingtin toxicity and clearance in mice.丝氨酸421调节小鼠中突变型亨廷顿蛋白的毒性和清除。
J Clin Invest. 2016 Sep 1;126(9):3585-97. doi: 10.1172/JCI80339. Epub 2016 Aug 15.
6
Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.在亨廷顿舞蹈症小鼠模型中降低突变型亨廷顿蛋白表达以改善疾病的神经元靶点。
Nat Med. 2014 May;20(5):536-41. doi: 10.1038/nm.3514. Epub 2014 Apr 28.
7
Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.亨廷顿病的非细胞自主和表观遗传机制。
Int J Mol Sci. 2021 Nov 19;22(22):12499. doi: 10.3390/ijms222212499.
8
Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice.在 BACHD 小鼠中,突变型亨廷顿蛋白在小胶质细胞中的表达既不是必需的,也不是充分的致病条件,不足以引起亨廷顿病样表型。
Hum Mol Genet. 2019 May 15;28(10):1661-1670. doi: 10.1093/hmg/ddz009.
9
Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.小分子蛋白二硫键异构酶调节剂可减轻亨廷顿病模型小鼠中突变型亨廷顿蛋白的毒性,并抑制内质网应激。
Hum Mol Genet. 2018 May 1;27(9):1545-1555. doi: 10.1093/hmg/ddy061.
10
Autophagy Activation by Transcription Factor EB (TFEB) in Striatum of HDQ175/Q7 Mice.转录因子EB(TFEB)在HDQ175/Q7小鼠纹状体中激活自噬
J Huntingtons Dis. 2016 Oct 1;5(3):249-260. doi: 10.3233/JHD-160211.

引用本文的文献

1
Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?增强大脑清理能力:靶向泛素蛋白酶体系统基因能否提供神经保护?
Mol Neurobiol. 2025 Aug 16. doi: 10.1007/s12035-025-05263-z.
2
Nemo-like kinase disrupts nuclear import and drives TDP43 mislocalization in ALS.尼莫样激酶破坏核输入并导致肌萎缩侧索硬化症中TDP43的错误定位。
J Clin Invest. 2025 Jun 24;135(17). doi: 10.1172/JCI188138. eCollection 2025 Sep 2.
3
Huntingtin interactome reveals huntingtin role in regulation of double strand break DNA damage response (DSB/DDR), chromatin remodeling and RNA processing pathways.亨廷顿相互作用组揭示了亨廷顿蛋白在双链断裂DNA损伤反应(DSB/DDR)、染色质重塑和RNA加工途径调控中的作用。
bioRxiv. 2024 Dec 27:2024.12.27.630542. doi: 10.1101/2024.12.27.630542.
4
Abnormal protein post-translational modifications induces aggregation and abnormal deposition of protein, mediating neurodegenerative diseases.异常的蛋白质翻译后修饰会诱导蛋白质聚集和异常沉积,介导神经退行性疾病。
Cell Biosci. 2024 Feb 12;14(1):22. doi: 10.1186/s13578-023-01189-y.
5
Reduction of nemo-like kinase increases lysosome biogenesis and ameliorates TDP-43-related neurodegeneration.抑制 Nemo 样激酶可增加溶酶体生物发生并改善 TDP-43 相关的神经退行性变。
J Clin Invest. 2023 Aug 15;133(16):e138207. doi: 10.1172/JCI138207.
6
Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington's Disease.蛋白激酶CK2及其作为亨廷顿舞蹈病治疗靶点的潜在作用。
Biomedicines. 2022 Aug 15;10(8):1979. doi: 10.3390/biomedicines10081979.
7
Inhibition of p38 Mitogen-Activated Protein Kinase Ameliorates HAP40 Depletion-Induced Toxicity and Proteasomal Defect in Huntington's Disease Model.抑制p38丝裂原活化蛋白激酶可改善亨廷顿病模型中HAP40缺失诱导的毒性和蛋白酶体缺陷。
Mol Neurobiol. 2021 Jun;58(6):2704-2723. doi: 10.1007/s12035-020-02280-y. Epub 2021 Jan 25.
8
Nemo-Like Kinase in Development and Diseases: Insights from Mouse Studies.Nemo 样激酶在发育和疾病中的作用:来自小鼠研究的启示。
Int J Mol Sci. 2020 Dec 2;21(23):9203. doi: 10.3390/ijms21239203.
9
How Do Post-Translational Modifications Influence the Pathomechanistic Landscape of Huntington's Disease? A Comprehensive Review.翻译后修饰如何影响亨廷顿舞蹈症的病理机制格局?一项综合综述。
Int J Mol Sci. 2020 Jun 16;21(12):4282. doi: 10.3390/ijms21124282.

本文引用的文献

1
The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease.亨廷顿病中突变型亨廷顿蛋白-蛋白相互作用失调的病理生物学。
J Neurochem. 2019 Nov;151(4):507-519. doi: 10.1111/jnc.14853. Epub 2019 Sep 15.
2
CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.CAG 重复序列而非多聚谷氨酰胺长度决定亨廷顿病发病时间。
Cell. 2019 Aug 8;178(4):887-900.e14. doi: 10.1016/j.cell.2019.06.036.
3
Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease.用于亨廷顿病治疗的突变 HTT 的等位基因选择性转录抑制。
Nat Med. 2019 Jul;25(7):1131-1142. doi: 10.1038/s41591-019-0478-3. Epub 2019 Jul 1.
4
Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease.亨廷顿舞蹈病疾病修饰的亨廷顿蛋白降低策略
Neuron. 2019 May 22;102(4):899. doi: 10.1016/j.neuron.2019.05.001.
5
Targeting Huntingtin Expression in Patients with Huntington's Disease.靶向亨廷顿病患者的亨廷顿蛋白表达。
N Engl J Med. 2019 Jun 13;380(24):2307-2316. doi: 10.1056/NEJMoa1900907. Epub 2019 May 6.
6
The effects of huntingtin-lowering: what do we know so far?降低亨廷顿蛋白的作用:我们目前了解到了什么?
Degener Neurol Neuromuscul Dis. 2019 Mar 8;9:3-17. doi: 10.2147/DNND.S163808. eCollection 2019.
7
Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.去泛素化酶 Usp12 发挥非催化作用,诱导自噬,并在亨廷顿病模型中提供神经保护。
Nat Commun. 2018 Sep 28;9(1):3191. doi: 10.1038/s41467-018-05653-z.
8
Therapeutic approaches to Huntington disease: from the bench to the clinic.亨廷顿病的治疗方法:从实验室到临床。
Nat Rev Drug Discov. 2018 Oct;17(10):729-750. doi: 10.1038/nrd.2018.133. Epub 2018 Sep 21.
9
A role for autophagy in Huntington's disease.自噬在亨廷顿病中的作用。
Neurobiol Dis. 2019 Feb;122:16-22. doi: 10.1016/j.nbd.2018.08.010. Epub 2018 Aug 24.
10
Selective autophagy as a potential therapeutic target for neurodegenerative disorders.选择性自噬作为神经退行性疾病的潜在治疗靶点。
Lancet Neurol. 2018 Sep;17(9):802-815. doi: 10.1016/S1474-4422(18)30238-2.